Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy

被引:3
|
作者
Jahromi, BS
Hill, MD
Holmes, K
Hutchison, S
Tucker, WS
Chiu, B
机构
[1] Univ Chicago, Neurosurg Sect, Ctr Med, Chicago, IL 60637 USA
[2] Univ Toronto, St Michaels Hosp, Dept Cardiol, Toronto, ON M5B 1W8, Canada
[3] Univ Toronto, St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada
[4] Univ Toronto, St Michaels Hosp, Dept Neurosurg, Toronto, ON M5B 1W8, Canada
[5] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[6] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
关键词
D O I
10.1017/S0317167100003048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Seroepidemiological studies have shown an association between raised antibody titres against Chlamydia pneumoniae, and carotid atherosclerosis or stroke. However, direct evidence for a causal link between arterial infection with C. pneumoniae and carotid disease remains weak. We hypothesized that long-term follow-up of patients with pathologically-proven arterial C. pneumoniae infection might provide further insight into the role of C. pneumoniae in carotid atherosclerosis. Methods: We followed a cohort of 70 carotid endarterectomy patients for ipsilateral restenosis, contralateral progression, and all-cause mortality (four year median follow-up period). All patients had presence or absence of C. pneumoniae in their carotid plaques documented by immunohistochemistry after endarterectomy. A survival function was generated and the log-rank test was used to assess the difference in survival between subjects with and without documented chlamydial infection in their plaque. Results: Baseline demographic and cardiovascular risk factors were similar between the two groups, and survival analysis demonstrated no difference (p>0.05) in all-cause mortality, or all-cause mortality combined with restenosis and progression. Conclusions: Our data finds no causal role for C. pneumoniae in restenosis or progression of carotid disease or mortality in this patient population with advanced carotid atherosclerosis.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 50 条
  • [21] Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population
    Maeda, N
    Sawayama, Y
    Tatsukawa, M
    Shimizu, C
    Kashiwagi, S
    Hayashi, J
    ATHEROSCLEROSIS, 2002, 164 (02) : 313 - 319
  • [22] An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis
    Kawamoto, R
    Doi, T
    Tokunaga, H
    Konishi, I
    INTERNAL MEDICINE, 2001, 40 (03) : 208 - 213
  • [23] Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis
    Apfalter, P
    Hammerschlag, MR
    Boman, J
    STROKE, 2003, 34 (07) : E73 - E74
  • [24] Effect on carotid atherosclerosis of levofloxacin plus probucol for Chlamydia pneumoniae infection
    Sawayama, Y.
    Tatsukawa, M.
    Kikuchi, K.
    Okada, K.
    Maeda, N.
    Hayashi, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 574 - 575
  • [25] Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
    Chiu, B
    Viira, E
    Tucker, W
    Fong, IW
    CIRCULATION, 1997, 96 (07) : 2144 - 2148
  • [26] Chlamydia pneumoniae and atherosclerosis - an update
    Saikku, P
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, : 53 - 56
  • [27] Chlamydia pneumoniae infection and atherosclerosis
    Marre, R
    Essig, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (36) : 1092 - 1095
  • [28] Chlamydia pneumoniae and atherosclerosis.
    Rutherford J.D.
    Current Atherosclerosis Reports, 2000, 2 (3) : 218 - 225
  • [29] CHLAMYDIA-PNEUMONIAE AND ATHEROSCLEROSIS
    BLANCHARD, T
    BAILEY, R
    HOLLAND, M
    MABEY, D
    LANCET, 1993, 341 (8848): : 825 - 825
  • [30] Epidemiology of Chlamydia pneumoniae in atherosclerosis
    Saikku, P
    AMERICAN HEART JOURNAL, 1999, 138 (05) : S500 - S503